Table of Contents

<< Previous Issue

Aug 2023 (Vol: 2023, Issue: 8)

Next Issue >>

Download pdf of entire issue

Section: Licensing
Agios signs US$147.5 M License Deal with Alnylam’s RNAi therapeutic for Polycythemia Vera Published: 22 Aug-2023
By: Shweta Gupta
Abstract Fulltext:
Section: Mergers & Acquisitions
Biogen to Acquire Reata for US$7.3 B for Rare Disease Portfolio Published: 1 Aug-2023
By: Lalit Mishra
Abstract Fulltext:
Section: Research & Development
Roche Signs US$2.8 B Deal with Alnylam to Develop RNAi Therapeutic for Hypertension Published: 2 Aug-2023
By: Amit Kaushik
Abstract Fulltext:
Astellas Enters into Collaborations with PeptiDream and Cullgen to Advance Targeted Protein Degraders Published: 8 Aug-2023
By: Ashish Tripathi
Abstract Fulltext:

Login

Login

Username:

Password:

Keep me logged in

Login Problems? Subscribe

IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents